Vidya Mave News Today

The study ‘One to Three’ will compare the treatment completion of daily dose of Rifapentine and Isoniazid for a month (1HP) to the weekly dose of Rifapentine and Isoniazid for three months (3HP) in persons living with HIV in Pune.

Two clinical trials show how Levofloxacin, given once daily to children over six months, prevented infection in five-year-olds exposed to MDR-TB by 56 per cent and in adolescents by 45 per cent

TB Aftermath has been underway since January 2021 in association with the National Tuberculosis Elimination Programme (NTEP).

With the next G20 Chief Science Advisors Roundtable (CSAR) scheduled to take place in Gujarat in August, insights emerging from these side events will be documented in the form of a report and shared with relevant stakeholders to enable effective discussions during the G20-CSAR meeting.

Last year, based on Shorter Treatment for Minimal Tuberculosis in Children (SHINE) research, the WHO strongly recommended shortening the TB treatment duration in non-severe paediatric TB cases from six-four months.

Dr Sanjiv Thakur, Dean of BJ Government Medical College said that for decades, the college has been conducting many clinical research studies among people affected by TB and HIV.

A major trial of an alternative four-month regimen reported disappointing findings. We unpack them and look the prospects now for shortening TB treatment.